Michels, Shannon; Barron, Rich; Reynolds, Matthew; … - In: PharmacoEconomics 30 (2012) 9, pp. 809-823
<Emphasis Type="Bold">Background and Objective: Febrile neutropenia (FN) is a potentially life-threatening condition that may develop in cancer patients treated with myelosuppressive chemotherapy and result in considerable costs. This study was designed to estimate US healthcare utilization and costs in those...</emphasis>